Medicover AB (publ)
MCVEF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -15.68 | 1.46 | -1.43 | 0.16 |
| FCF Yield | 6.40% | 6.21% | 1.97% | 2.80% |
| EV / EBITDA | 19.57 | 9.61 | 11.11 | 17.38 |
| Quality | ||||
| ROIC | 2.79% | 2.88% | 2.47% | 8.16% |
| Gross Margin | 21.43% | 20.58% | 22.22% | 28.68% |
| Cash Conversion Ratio | 13.03 | 8.69 | 8.60 | 1.51 |
| Growth | ||||
| Revenue 3-Year CAGR | 11.47% | 8.23% | 14.81% | 17.72% |
| Free Cash Flow Growth | 47.72% | 219.26% | -74.15% | 37.13% |
| Safety | ||||
| Net Debt / EBITDA | 6.83 | 3.70 | 4.17 | 2.48 |
| Interest Coverage | 1.16 | 1.19 | 1.58 | 7.93 |
| Efficiency | ||||
| Inventory Turnover | 23.78 | 23.35 | 20.18 | 13.64 |
| Cash Conversion Cycle | -2.98 | 34.69 | 50.78 | 55.35 |